AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
NASDAQ:ANGO
Price:
9.5
USD
-3.36%
Market Closed
Market Cap:
384.5m
USD
Balance Sheet
Balance Sheet Decomposition
AngioDynamics Inc
AngioDynamics Inc
| Current Assets | 175.4m |
| Cash & Short-Term Investments | 54.1m |
| Receivables | 43.2m |
| Other Current Assets | 78.1m |
| Non-Current Assets | 116.2m |
| PP&E | 37.8m |
| Intangibles | 73.1m |
| Other Non-Current Assets | 5.3m |
Balance Sheet
AngioDynamics Inc
AngioDynamics Inc
Currency: USD
Millions
Annual
| May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18
|
32
|
48
|
74
|
228
|
54
|
48
|
29
|
45
|
76
|
|
| Cash Equivalents |
18
|
32
|
48
|
74
|
228
|
54
|
48
|
29
|
45
|
76
|
|
| Short-Term Investments |
4
|
2
|
1
|
1
|
0
|
0
|
3
|
2
|
1
|
1
|
|
| Total Receivables |
58
|
53
|
45
|
39
|
44
|
34
|
35
|
52
|
53
|
50
|
|
| Accounts Receivables |
58
|
53
|
45
|
39
|
44
|
31
|
35
|
52
|
53
|
44
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
6
|
|
| Inventory |
67
|
55
|
55
|
49
|
40
|
60
|
49
|
51
|
55
|
61
|
|
| Other Current Assets |
3
|
4
|
6
|
4
|
4
|
4
|
6
|
9
|
10
|
6
|
|
| Total Current Assets |
151
|
146
|
154
|
168
|
315
|
153
|
141
|
143
|
164
|
193
|
|
| PP&E Net |
55
|
48
|
45
|
43
|
24
|
39
|
47
|
52
|
50
|
41
|
|
| PP&E Gross |
55
|
48
|
45
|
43
|
24
|
39
|
47
|
52
|
50
|
41
|
|
| Accumulated Depreciation |
36
|
44
|
50
|
49
|
42
|
41
|
46
|
51
|
59
|
73
|
|
| Intangible Assets |
182
|
167
|
146
|
130
|
145
|
197
|
169
|
152
|
111
|
77
|
|
| Goodwill |
361
|
361
|
361
|
361
|
348
|
201
|
201
|
201
|
159
|
0
|
|
| Other Long-Term Assets |
25
|
4
|
2
|
3
|
4
|
5
|
4
|
4
|
49
|
6
|
|
| Other Assets |
361
|
361
|
361
|
361
|
348
|
201
|
201
|
201
|
159
|
0
|
|
| Total Assets |
773
N/A
|
726
-6%
|
708
-3%
|
706
0%
|
836
+19%
|
594
-29%
|
561
-6%
|
553
-2%
|
533
-4%
|
318
-40%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
23
|
16
|
18
|
16
|
23
|
19
|
20
|
28
|
40
|
38
|
|
| Accrued Liabilities |
18
|
22
|
39
|
34
|
38
|
32
|
38
|
37
|
29
|
37
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
16
|
5
|
5
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
11
|
13
|
10
|
2
|
5
|
1
|
0
|
9
|
15
|
17
|
|
| Total Current Liabilities |
61
|
67
|
72
|
57
|
73
|
51
|
58
|
74
|
84
|
91
|
|
| Long-Term Debt |
129
|
104
|
91
|
87
|
124
|
40
|
20
|
25
|
50
|
0
|
|
| Deferred Income Tax |
1
|
22
|
26
|
17
|
15
|
24
|
20
|
16
|
13
|
5
|
|
| Other Liabilities |
37
|
26
|
4
|
2
|
9
|
24
|
24
|
13
|
8
|
16
|
|
| Total Liabilities |
228
N/A
|
219
-4%
|
193
-12%
|
163
-16%
|
222
+36%
|
139
-37%
|
122
-12%
|
128
+5%
|
154
+20%
|
112
-27%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
28
|
16
|
11
|
5
|
67
|
100
|
132
|
158
|
211
|
395
|
|
| Additional Paid In Capital |
520
|
526
|
533
|
544
|
555
|
562
|
574
|
587
|
599
|
610
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
2
|
2
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Other Equity |
1
|
1
|
1
|
0
|
1
|
1
|
3
|
1
|
5
|
4
|
|
| Total Equity |
545
N/A
|
507
-7%
|
515
+2%
|
543
+5%
|
615
+13%
|
455
-26%
|
440
-3%
|
425
-3%
|
378
-11%
|
206
-46%
|
|
| Total Liabilities & Equity |
773
N/A
|
726
-6%
|
708
-3%
|
706
0%
|
836
+19%
|
594
-29%
|
561
-6%
|
553
-2%
|
533
-4%
|
318
-40%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
36
|
36
|
37
|
37
|
38
|
38
|
39
|
39
|
40
|
40
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
